Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Contineum Therapeutics, Inc. | 192,000 | reported | 30 Jan 2026 | tx 3+402,000 |
| SOPHIRIS BIO INC. | 103,000 | reported | 19 Dec 2019 | tx 8+768,367 |
| ANADYS PHARMACEUTICALS INC | 50,000 | reported | 20 Jan 2011 | tx 4+179,836 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 30 Jan 2026 | GRANT_AWARD | Contineum Therapeutics, Inc. | 192,000 | 0.00 USD | deriv |
| 31 Jan 2025 | GRANT_AWARD | Contineum Therapeutics, Inc. | 110,000 | 0.00 USD | deriv |
| 24 May 2024 | GRANT_AWARD | Contineum Therapeutics, Inc. | 100,000 | 0.00 USD | deriv |
| 19 Dec 2019 | GRANT_AWARD | SOPHIRIS BIO INC. | 103,000 | 0.36 USD | deriv |
| 31 Dec 2018 | GRANT_AWARD | SOPHIRIS BIO INC. | 205,667 | 0.00 USD | deriv |
| 06 Dec 2017 | GRANT_AWARD | SOPHIRIS BIO INC. | 12,768 | 0.00 USD | deriv |
| 07 Dec 2016 | GRANT_AWARD | SOPHIRIS BIO INC. | 154,000 | 0.00 USD | deriv |
| 27 May 2016 | GRANT_AWARD | SOPHIRIS BIO INC. | 103,467 | 0.00 USD | deriv |
| 05 Feb 2015 | GRANT_AWARD | SOPHIRIS BIO INC. | 37,058 | 0.00 USD | deriv |
| 25 Oct 2013 | GRANT_AWARD | SOPHIRIS BIO INC. | 147,727 | 0.00 USD | deriv |
| 20 Aug 2013 | PURCHASE | SOPHIRIS BIO INC. | 4,680 | 4.25 USD | |
| 20 Jan 2011 | GRANT_AWARD | ANADYS PHARMACEUTICALS INC | 50,000 | 0.00 USD | deriv |
| 13 Dec 2010 | GRANT_AWARD | ANADYS PHARMACEUTICALS INC | 51,750 | 0.00 USD | deriv |
| 03 Dec 2009 | GRANT_AWARD | ANADYS PHARMACEUTICALS INC | 53,086 | 0.00 USD | deriv |
| 18 Aug 2009 | GRANT_AWARD | ANADYS PHARMACEUTICALS INC | 25,000 | 0.00 USD | deriv |